IP Library › Assignment 006167/0046
Patent Assignment
Reel/Frame 006167/0046

Assignment of Assignors Interest.

Recorded: 1991-11-18 Pages: 14
Assignor
Assignee
SCRIPPS RESEARCH INSTITUTE, THE, A CORP. OF CA
10666 NORTH TORREY PINES ROAD, LA JOLLA, CALIFORNIA, 92037
Covered Properties (221)
Induction of Immunological Tolerance
Patent: 4,191,668 →
Application: 05/764,586 →
Induction of Immunological Tolerance
Patent: 4,388,441 →
Application: 05/937,574 →
Induction of Immunological Tolerance
Patent: 4,222,907 →
Application: 05/945,700 →
Immunochemical Conjugates: Method and Composition
Patent: 4,220,565 →
Application: 06/004,333 →
Immunochemical Conjugates: Method and Composition
Patent: 4,276,206 →
Application: 06/120,067 →
Immunochemical Conjugates: Method and Composition
Patent: 4,253,995 →
Application: 06/120,068 →
Immunochemical Conjugates: Method and Composition
Patent: 4,253,996 →
Application: 06/120,988 →
Solid Phase Anti-C3 Assay for Detection of Immune Complexes
Patent: 4,342,566 →
Application: 06/123,562 →
Detection of Mycoplasma Infection in Cell Cultures
Patent: 4,387,161 →
Application: 06/283,934 →
Ultrapurification of Factor Viii Using Monoclonal Antibodies
Patent: 4,361,509 →
Application: 06/330,105 →
Synthetic Foot and Mouth Disease Antigen
Application: 06/368,308 →
Immune Modulator Peptides
Patent: 4,415,493 →
Application: 06/377,223 →
Broad Spectrum Influenza Antisera
Application: 06/410,455 →
Microplate Washer
Patent: 4,496,657 →
Application: 06/434,308 →
Modulation of Animal Cellular Responses with Compositions Containing 8-Substituted Guanine Derivatives
Patent: 4,539,205 →
Application: 06/439,846 →
Synthetic Heat-Stable Enterotoxin Polypeptide of Escherichia Coli
Patent: 4,545,931 →
Application: 06/455,265 →
Synthetic Picornavirus Antigen
Application: 06/478,847 →
New Factor Viii Coagulant Polypeptides
Application: 06/481,105 →
Method and System for Detection of Complement Pathway Activation
Patent: 4,642,284 →
Application: 06/503,705 →
Synthetic Polypeptides Corresponding to Portions of Proteinoids Translated from Brain-Specific Mrnas, Receptors, Methods and Diagnostics Using the Same
Application: 06/516,136 →
Polypeptide-Induced Monoclonal Receptors to Protein Ligands
Application: 06/524,084 →
Broad Spectrum Influenza Antisera
Patent: 4,625,015 →
Application: 06/527,401 →
Receptors Specific for Hapten-Modified Self Proteins
Application: 06/540,839 →
Modulation of Animal Cellular Responses with Compositions Containing 8-Substituted Guanine Derivatives
Patent: 4,643,992 →
Application: 06/546,679 →
System and Method for Complement Pathway Analysis
Application: 06/552,158 →
Synthetic Heat-Stable Enterotoxin Polypeptide of Escherichia Coli and Multimers Thereof
Patent: 4,886,663 →
Application: 06/559,469 →
Ultrapurification of Factor Viii Using Monoclonal Antibodies
Patent: 32,011 →
Application: 06/563,795 →
Anti-Idiotype Antibodies Induced by Synthetic Polypeptides
Application: 06/566,172 →
SV40 Expression Vector Containing Hbxag as an Expression Marker
Application: 06/587,570 →
Synthetic Hepatitis B Virus Vaccine Including Both T Cell and B Cell Determinants
Patent: 4,599,231 →
Application: 06/587,983 →
Synthetic Hepatitis B Virus Vaccine Including Both T Cell and B Cell Determinants
Patent: 4,599,230 →
Application: 06/588,122 →
Antibodies to Human Interleukin-2 Induced by Synthetic Polypeptides
Patent: 4,636,463 →
Application: 06/597,179 →
Leukemia-Associated Virus Immunogen, Vaccine and Assay
Patent: 4,663,436 →
Application: 06/603,348 →
Vascular Prosthesis
Patent: 4,687,482 →
Application: 06/604,996 →
Diagnostic System for the Detection of Cytomegalovirus
Patent: 4,818,678 →
Application: 06/607,387 →
Method for the Preparation of Anti-Receptor Antibodies
Patent: 4,683,295 →
Application: 06/614,102 →
Diagnostic Assay for Inhibitor of Tissue-Type and Urokinase-Type Plasminogen Activators
Patent: 4,791,068 →
Application: 06/623,357 →
Monoclonal Antibody Directed to Human Ganglioside GD2
Patent: 4,675,287 →
Application: 06/634,687 →
Synthetic Polypeptides and Antibodies Related to Epstein-Barr Virus Nuclear Antigen
Patent: 4,654,419 →
Application: 06/638,726 →
Murine Monoclonal Antibody Combining Site to Human C3B Receptor (CR1)
Patent: 4,672,044 →
Application: 06/644,217 →
Sv 40 Expression Vector Containing Hbxag as an Expression Marker
Patent: 4,777,240 →
Application: 06/648,142 →
Molecules with Antibody Combining Sites That Bind to Hydrolytic Transition States
Patent: 4,659,567 →
Application: 06/648,406 →
Vaccine Utilizing an Avirulent Strain of Salmonella Typhimurium
Patent: 4,764,370 →
Application: 06/650,282 →
Merozoite Surface Glycoproteins
Patent: 4,835,259 →
Application: 06/650,810 →
Synthetic Picornavirus Antigen
Patent: 4,769,237 →
Application: 06/653,475 →
Aotus Interspecies Hybridomas and Monoclonal Receptors Produced Thereby
Patent: 4,746,612 →
Application: 06/660,478 →
New Factor Viii Coagulant Polypeptides
Patent: 4,657,894 →
Application: 06/673,916 →
Synthetic Foot and Mouth Disease Antigen
Patent: 4,544,500 →
Application: 06/682,819 →
Polypeptide-Induced Monoclonal Receptors to Protein Ligands
Patent: 5,030,565 →
Application: 06/701,954 →
Proteinaceous Antigens with Conformation-Independent and Conformation- Dependent Determinants
Patent: 4,683,136 →
Application: 06/708,746 →
Cytotoxic Compositions
Patent: 4,661,347 →
Application: 06/709,007 →
Diagnostic Assay for the Presence of Apolipoproteins Associated with Plasma High Density Lipoproteins
Patent: 4,677,057 →
Application: 06/710,038 →
Means for Sequential Solid Phase Organic Synthesis and Methods Using the Same
Patent: 4,631,211 →
Application: 06/715,654 →
Detection of Activated Platelets with Antibodies
Patent: 4,820,505 →
Application: 06/720,032 →
Diagnostic System for the Detection of Cytomegalovirus
Patent: 4,783,399 →
Application: 06/726,454 →
Acute Phase Protein Modulating Endotoxic Activity of Lipopolysaccharides, Compositions and Methods
Application: 06/728,833 →
Polypeptide-Induced Monoclonal Receptors to Protein Ligands
Application: 06/736,545 →
Treatment of Factor Viii Inhibitors
Patent: 4,649,132 →
Application: 06/738,134 →
Synthetic Polypeptide Corresponding to a Portion of the Heat-Labile Enterotoxin of Escherichia Coli, Compositions and Methods Therewith
Application: 06/760,753 →
Hybrid Ligand Directed to Activation of Cytotoxic Effector T Lymphocytes and Target Associated Antigen
Patent: 5,078,998 →
Application: 06/762,048 →
Anti-Idiotype Antibodies Induced by Synthetic Polypeptides
Patent: 5,068,177 →
Application: 06/762,698 →
Synthetic Polypeptides for Detecting Mycobacterial Infections
Patent: 4,689,397 →
Application: 06/765,048 →
Merozoite Surface Antigens
Application: 06/775,758 →
Factor Viii Coagulant Polypeptides and Monoclonal Antibodies to Them
Patent: 4,857,635 →
Application: 06/778,297 →
Platelet Binding Inhibitors
Patent: 4,683,291 →
Application: 06/791,872 →
Antimicrobial Chemotherapeutic Potentiation Using Substituted Nucleoside Derivatives
Patent: 4,746,651 →
Application: 06/798,629 →
Modulation of Animal Cellular Responses with Compositions Containing Isoxanthopterin-8-(1'-Beta-Aldoglycosidyl) Derivatives
Application: 06/808,886 →
Leukemia-Associated Virus Immunogen, Vaccine and Assay
Patent: 4,794,168 →
Application: 06/813,279 →
Method and Additives for Improving the Quality and Shelf Life of Stored Blood
Patent: 4,774,088 →
Application: 06/817,189 →
Lymphocyte-Activating Polypeptides
Patent: 4,683,221 →
Application: 06/817,526 →
Agents Inhibiting Replication of Reverse Transcriptase-Dependent Viruses
Application: 06/825,215 →
Cellular Fibronectin: Polypeptides, Anti-Polypeptide Antibodies and Assay Methods
Patent: 4,980,279 →
Application: 06/852,127 →
Substantially Pure Cytotoxicity Triggering Factor
Patent: 4,785,077 →
Application: 06/859,604 →
Peptides That Inhibit Von Willebrand Factor Binding
Application: 06/869,188 →
Neisseria Gonorrhoeae Lectin Useful as a Vaccine and Diagnostic Marker
Application: 06/875,477 →
In Vivo Active Compound Assembly
Application: 06/882,082 →
Erythrocytic Membrane Antigens of P. Falciparum-Infected Erythrocytes
Application: 06/891,752 →
Apolipoprotein B-Specific Monoclonal Antibodies Produced by Two Novel Hybridomas
Application: 06/893,659 →
Gene Encoding an Inhibitor of Tissue-Type and Urokinase-Type Plasminogen Activators
Patent: 4,952,512 →
Application: 06/897,990 →
In Situ Active Compound Assembly
Application: 06/906,143 →
Neisseria Gonorrhoeae Lectin Useful as a Vaccine and Diagnostic Marker and Means for Producing This Lectin
Patent: 4,786,592 →
Application: 06/907,115 →
Molecules with Antibody Combining Sites That Exhibit Catalytic Properties
Application: 06/908,313 →
Ultrapurification of Factor Ix and Other Vitamin K-Dependent Proteins
Application: 06/910,315 →
Hybridomas and Monoclonal Paratopic Molecules to Apolipoprotein A-I
Patent: 5,126,240 →
Application: 06/913,061 →
Assay Method and Diagnostic System for Determining the Ratio of Apo B-100 to Apo a-I in a Blood Sample
Patent: 4,828,986 →
Application: 06/913,140 →
Ex Vivo Effector Cell Activation for Target Cell Killing
Patent: 4,844,893 →
Application: 06/916,173 →
Novel Immunochemical Method for Assaying Stable Glycosylated Hemoglobin
Patent: 4,876,188 →
Application: 06/932,442 →
Cell Surface Antigen Detection Method
Patent: 4,810,632 →
Application: 06/936,125 →
Synthetic Polypeptides and Antibodies Related to Epstein-Barr Virus Early Antigen-Diffuse
Patent: 4,879,213 →
Application: 06/938,643 →
T Cell Epitopes of the Hepatitis B Virus Nucleocapsid Protein
Patent: 4,818,527 →
Application: 06/939,617 →
Receptors Specific for Hapten-Modified Self Proteins
Patent: 4,778,752 →
Application: 06/941,517 →
Acute Phase Protein Modulating Endotoxic Activity of Lipopolysaccharides, Compositions and Methods
Application: 07/006,710 →
Treatment of Factor Viii Inhibitors
Patent: 4,769,336 →
Application: 07/013,776 →
Modulation of Animal Cellular Responses with Compositions Containing 8-Substituted Guanine Derivatives
Patent: 4,849,411 →
Application: 07/014,618 →
New Factor Viii Coagulant Polypeptides
Application: 07/016,214 →
Monoclonal Antibodies to Human Pancreatic Cancer
Application: 07/016,552 →
Mycobacterial Recombinants and Peptides
Patent: 4,952,395 →
Application: 07/019,529 →
Synthetic Polypeptides and Antibodies Related to Epstein-Barr Virus Nuclear Antigen
Application: 07/029,860 →
Human Tissue Factor Related Dna Segments, Polypeptides and Antibodies
Application: 07/033,047 →
Recombinant Factor Viiic Derived Fragments
Patent: 4,980,456 →
Application: 07/034,828 →
Factor Viii Coagulant Polypeptides
Patent: 4,886,876 →
Application: 07/037,615 →
Polypeptide-Induced Monoclonal Receptors to Protein Ligands
Patent: 5,015,571 →
Application: 07/039,534 →
Protein Fragments Containing Factor Viii Binding Domaian of Von Willebrand Factor
Patent: 5,043,429 →
Application: 07/045,032 →
SV40 Expression Vector Containing Hbxag as an Expression Marker
Patent: 4,942,125 →
Application: 07/054,424 →
Antibody Combining Sites That Exhibit Amide or Ester Synthase Activity
Patent: 4,900,674 →
Application: 07/055,177 →
Synthetic Polypeptides Corresponding to Portions of Proteinoids Translated from Brain-Specific Mrnas, Receptors, Methods and Diagnostics Using the Same
Patent: 4,900,811 →
Application: 07/058,620 →
Peptides and Antibodies That Inhibit Platelet Adhesion
Application: 07/070,953 →
Synthetic Polypeptide Corresponding to a Portion of the Heat-Labile Enterotoxin of Escherichia Coli, Compositions and Methods of Therewith
Patent: 4,758,655 →
Application: 07/071,606 →
Flouroplastic Immunoaffinity Columns for Purification of Blood Proteins
Patent: 4,831,118 →
Application: 07/083,670 →
Antibody Combining Sites That Exhibit Stereoselective Synthase Activity, and Methods Using the Same
Patent: 5,079,152 →
Application: 07/083,681 →
Antibodies Which Catalyze Hydrolysis of Ester Bonds
Patent: 5,030,717 →
Application: 07/086,896 →
Synthetic Polypeptides and Receptor Molecules Derived Therefrom and Methods of Use
Patent: 4,889,800 →
Application: 07/088,146 →
Method for Reducing Bacterial Endotoxin Contamination in Solutions of Macromolecules
Patent: 4,808,314 →
Application: 07/098,299 →
T Cell Epitopes of the Hepatitis B Virus Nucleocapsid Protein
Patent: 4,882,145 →
Application: 07/106,538 →
In Situ Active Compound Assembly
Patent: 4,812,449 →
Application: 07/108,833 →
,Diagnostic Methods and Systems for Quantifying Apo Ai
Patent: 5,055,396 →
Application: 07/116,248 →
Assay for Epstein-Barr Virus Infection with Solid Phase Bound Synthetic Polypeptides
Patent: 5,116,725 →
Application: 07/117,241 →
Potentiation of Erythropoiesis
Patent: 5,032,507 →
Application: 07/120,470 →
Proteolytic Fragments and Synthetic Peptides That Block the Binding of Von Willebrand Factor to the Platelet Membrane Glycoprotein
Application: 07/121,454 →
Inhibition of Arterial Thrombotic Occlusion or Thromboembolism
Patent: 5,084,274 →
Application: 07/121,702 →
Adenosines Deaminase-Stable Anti-Retroviral 2-Halo-2',3'-Dideoxy
Patent: 4,997,926 →
Application: 07/121,950 →
Cell Surface Antigen Detection Method
Patent: 5,176,998 →
Application: 07/124,905 →
Method of Inhibiting Platelet Dependent Arterial Thrombosis
Application: 07/125,178 →
Pulmonary Surfactant Protein and Related Polypeptide
Application: 07/141,200 →
Modulation of Animal Cellular Responses with Compositions Containing Isoxanthopterin-8-(1'-Beta-Aldoglycosidyl) Derivatives
Patent: 4,900,675 →
Application: 07/154,991 →
Mycobacterial Recombinants and Peptides
Patent: 4,976,958 →
Application: 07/159,667 →
Substituted Adenine Derivatives Useful in Treating Autoimmune Diseases
Application: 07/169,618 →
Peptides and Antibodies That Inhibit Platelet Adhesion
Patent: 5,114,842 →
Application: 07/175,342 →
Erythrocytic Membrane Antigens of P. Falciparum-Infected Erythrocytes
Patent: 5,019,511 →
Application: 07/183,456 →
Immunostimulating Guanosine Derivatives and Their Pharmaceutical Compositions
Patent: 5,093,318 →
Application: 07/190,694 →
Immunostimulating Guanine Derivatives, Compositions and Methods
Patent: 5,011,828 →
Application: 07/190,697 →
Antibodies to Human Papillomavirus Latent Proteins, Diagnostic Systems and Methods
Application: 07/194,407 →
Immunostimulating 7-Deaza-7-Oxa- and 7-Deaza-7-Oxo-Analogs of 8- Substituted-Guanine-9-(1'-Beta-D-Aldoglycosidyl) Derivatives and Methods of Treating Test Animals
Patent: 5,166,141 →
Application: 07/198,141 →
System and Method for Complement Pathway Analysis
Patent: 4,960,712 →
Application: 07/213,312 →
Synthetic Polypeptides and Antibodies Related to Epstein-Barr Virus Nuclear Antigen
Patent: 5,717,065 →
Application: 07/230,250 →
New Factor Viii Coagulant Polypeptides
Application: 07/232,795 →
Molecules with Antibody Combining Sites That Exhibit Catalytic Properties
Patent: 5,126,258 →
Application: 07/234,425 →
Methods for Increasing C1 Inhibitor Concentrations Using Interferon- Gamma and/or Interleukin-6
Patent: 5,271,931 →
Application: 07/244,265 →
Peptides and Antibodies That Inhibit Integrin-Ligand Binding
Patent: 5,149,780 →
Application: 07/252,674 →
Monoclonal Antibodies Against Receptor Induced Binding Sites
Application: 07/252,753 →
New Antiviral Agents
Application: 07/261,436 →
Peptides That Inhibit Von Willebrand Factor Binding
Application: 07/270,488 →
Method of Inhibiting Platelet Dependent Arterial Thrombosis
Patent: 4,929,602 →
Application: 07/275,330 →
Ultrapurification of Factor Ix and Other Vitamin K-Dependent Proteins
Patent: 5,055,557 →
Application: 07/275,466 →
Stabilization of Leukocytes
Patent: 4,923,797 →
Application: 07/277,256 →
Deletion Analogues of Magainin Peptides
Patent: 4,962,277 →
Application: 07/281,981 →
Pulmonary Surfactant Protein and Related Polypeptide
Patent: 5,164,369 →
Application: 07/293,201 →
Monoclonal Antibodies to Human Pancreatic Cancer
Application: 07/293,384 →
Polyvalent Metal Ion-Containing Antibody Combining Site Catalysts
Patent: 5,236,825 →
Application: 07/298,082 →
Use of Fibronectin Having a Variable Included Type Iii Repeat Sequence as a Marker for Toxemia in Pregnancy
Patent: 5,108,898 →
Application: 07/298,622 →
Substituted Adenine Derivatives Useful as Therapeutic Agents
Application: 07/323,350 →
Human Papillomavirus Latent Proteins, Diagnostic Polypeptides and Compositions of Systems and Methods
Patent: 5,180,806 →
Application: 07/323,614 →
Synthetic Polypeptides and Antibodies Related to Epstein-Barr Virus Nuclear Antigen
Patent: 33,897 →
Application: 07/330,320 →
Monoclonal Antibodies to Human Pancreatic Cancer
Patent: 4,962,048 →
Application: 07/333,848 →
Method for Tapping the Immunological Repertoire
Application: 07/353,235 →
Method for Tapping the Immunological Repertoire
Application: 07/353,241 →
Merozoite Surface Glycoproteins
Patent: 5,008,198 →
Application: 07/358,663 →
Modulation of Animal Cellular Responses with Compositions Containing 8-Substituted Guanine Derivatives
Patent: 4,948,730 →
Application: 07/361,974 →
Merozoite Surface Antigens
Patent: 4,978,621 →
Application: 07/366,191 →
Acute Phase Protein Modulating Endotoxic Activity of Lipopolysaccharides, Assay Methods and Polypeptides
Patent: 5,245,013 →
Application: 07/367,454 →
Substitution Analogues of Magainin Peptides
Application: 07/376,754 →
New Factor Viii Coagulant Polypeptides and Monoclonal Antibodies to Them
Application: 07/387,021 →
Methods and Compositions for Ameliorating the Symptoms of Sepsis
Application: 07/387,817 →
Drugs Effective Against Retroviruses
Patent: 5,177,083 →
Application: 07/405,834 →
Method for Producing Polymers Having a Preselected Activity
Application: 07/410,749 →
Peptides and Antibodies That Inhibit Integrin-Ligand Binding
Patent: 5,204,445 →
Application: 07/415,025 →
Monoclonal Antibodies Against Receptor-Induced Binding Sites
Application: 07/415,029 →
Apolipoprotein B-Specific Monoclonal Antibodies Produced by Two Novel Hybridomas
Patent: 5,330,910 →
Application: 07/415,432 →
Antibodies That Bind to a Ligand-Induced Binding Site on Gpiiia
Patent: 5,284,751 →
Application: 07/417,565 →
Catalysis of Diels-Alder Reactions, Methods and Catalyst Therefor
Application: 07/422,643 →
Stabilization of Leukocytes
Patent: 5,211,960 →
Application: 07/437,361 →
T Cell Epitopes of the Hepatitis B Virus Nucleocapsid Protein
Patent: 5,143,726 →
Application: 07/439,099 →
Peptides and Antibodies That Inhibit Integrin-Ligand Binding
Patent: 5,196,511 →
Application: 07/444,777 →
Method for Tapping the Immunological Repertoire
Application: 07/446,332 →
Adenosine Derivatives with Therapeutic Activity
Patent: 5,106,837 →
Application: 07/460,351 →
Proteolytic Fragments and Synthetic Peptides That Block the Binding of Von Willebrand Factor to the Platelet Membrane Glycoprotein Ib
Application: 07/460,674 →
Assay of Anti-Epstein-Barr Virus Nucler Antigen Antibodies with Synthetic Polypeptides
Patent: 5,122,448 →
Application: 07/463,505 →
Nucleic Acid Enzymes for Cleaving Dna
Application: 07/464,530 →
Molecules with Antibody Combining Sites That Catalyze Hydrolysis Reactions
Application: 07/470,924 →
Method for Producing Polymers Having a Preselected Activity
Application: 07/496,522 →
Method for Producing Polymers Having a Preselected Activity
Application: 07/497,106 →
Peptides That Inhibit Von Willebrand Factor Binding to the Platelet Gpib Receptor
Patent: 5,238,919 →
Application: 07/519,606 →
Intermediates in the Formation of the Calichemamicin and Esperimicin Oligosaccharides
Application: 07/520,245 →
Metal Binding Proteins
Application: 07/521,258 →
Cholera Toxin Gene Regulated by Growth Hormone Promoter
Patent: 5,223,610 →
Application: 07/528,852 →
Metal Binding Proteins
Application: 07/539,980 →
Diagnostic Systems and Methods Using Polypeptide Analogs of Apolipoprotein E
Patent: 5,168,045 →
Application: 07/540,363 →
Antibodies, Diagnostic Systems and Methods for Assaying SV40
Patent: 5,183,734 →
Application: 07/553,982 →
Amphiphilic Peptide Compositions and Analogues Thereof
Application: 07/554,422 →
Inhibition of Mac-1 Receptor Binding to Fibrinogen Using D30 Homologs
Application: 07/556,643 →
Phosphene Oxide-Terminated Allene-Ene-Yne Dna-Cleaving, Antitumor and Antibiotic Molecules
Patent: 5,229,375 →
Application: 07/561,455 →
Golfomycin Derivatives: Novel Fused Ring Cyclodecadiyne Derivatives Having Dna-Cleaving Properties and Antitumor Activity
Patent: 5,136,099 →
Application: 07/561,964 →
Modulation of Animal Cellular Responses with Compositions Containing 8-Substituted Guanine Derivatives and Interferons
Patent: 5,147,636 →
Application: 07/562,101 →
Diagnostic Assay for Inhibitor of Tissue-Type and Urokinase-Type Plasminogen Activators, and Gene Coding for the Inhibitor
Application: 07/573,485 →
Mycobacterial Recombinants and Peptides
Application: 07/574,439 →
Active Site of Interleukin-8: Polypeptide Analogs and Antibodies
Application: 07/581,673 →
Direct Cloning of Pcr Amplified Nucleic Acids
Application: 07/589,817 →
A Method of Diagnosing the Presence of Abormal Epithelial Tissue Using Monoclonal Antibodies to the A6B4 Cell Surface Protein
Patent: 5,320,942 →
Application: 07/591,105 →
Mutant Von Willebrand Factor Polypeptide Fragments
Application: 07/600,183 →
Therapeutic Fragments of Von Willebrand Factor
Application: 07/613,004 →
Gpibalpha Fragments and Recombinant Dna Expression Vectors
Patent: 5,340,727 →
Application: 07/613,083 →
Antibodies That Bind to a Ligand-Induced Binding Site on Integrin and Induce Integrin Activation
Patent: 5,306,620 →
Application: 07/613,357 →
Characterization of Platelet Aggregation Disorders
Patent: 5,196,309 →
Application: 07/614,723 →
Substitution Analogues of Magainin Peptides
Application: 07/615,125 →
Novel Pollypeptides for Promoting Cell Attachment
Application: 07/620,668 →
Methods and Compositions for Diagnosing Chronic Immune Thrombocytopenic Purpura
Patent: 5,177,188 →
Application: 07/620,669 →
Peptides and Antibodies That Inhibit Integrin-Ligand Binding
Patent: 5,262,520 →
Application: 07/620,823 →
Polypeptide Analogs of Apolipoprotein E, Diagnostic Systems and Methods Using the Analogs
Application: 07/625,093 →
Molecules with Anttibody Combining Sites That Catalyze Hydrolysis Reactions Through Use Fo Charge Hapten
Patent: 5,187,086 →
Application: 07/644,909 →
Polypeptides That Mimic Receptor-Induced Binding Sites, and Methods of Using Same
Patent: 5,372,933 →
Application: 07/654,839 →
Cell Surface Receptors Homologous to Coagulation Factors V and Viii
Application: 07/667,957 →
Method and Composition for Synthesizing Sialylated Glycosyl Compounds
Patent: 5,278,299 →
Application: 07/670,701 →
Dynemicin Analogs: Syntheses, Methods of Preparation and Use
Application: 07/673,199 →
Heteromeric Receptor Libraries Using Phagemids
Application: 07/683,602 →
Immunostimulating Guanine Derivatives, Compositions and Methods
Patent: 5,136,030 →
Application: 07/693,934 →
Intermediates in the Formation of the Calicheamicin and Esperamicin Oligosaccharides
Application: 07/695,251 →
Integrin Alpha Subunit Cytoplasmic Domain Polypeptides and Antibodies
Patent: 5,310,874 →
Application: 07/695,564 →
2-Substituted-(5S)-Hydroxymethyl-(3R,4R)-Dihydroxypyrrolidines
Application: 07/707,594 →
1, Omega-Dideoxy-Azasugars
Application: 07/707,600 →
New Factor Viii Coagulant Polypeptides
Patent: 5,214,033 →
Application: 07/730,193 →
Dynemicin Analogs: Syntheses, Methods of Preparation and Use
Application: 07/734,613 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Oct 20, 1980
From: KATZ DAVID H.
To: SCRIPPS CLINIC & RESEARCH FOUNDATION
Reel/Frame 003806/0623 →
Assignment of Assignors Interest. Oct 20, 1980
From: KATZ DAVID H.
To: SCRIPPS CLINIC & RESEARCH FOUNDATION
Reel/Frame 003806/0625 →
Assignment of Assignors Interest. Oct 20, 1980
From: KATZ DAVID H.
To: SCRIPPS CLINIC & RESEARCH FOUNDATION
Reel/Frame 003806/0624 →
Assignment of Assignors Interest. Sep 11, 1981
From: MC GARRITY, GERARD
To: INSTITUTE FOR MEDICAL RESEARCH THE, COPEWOOD ST., CAMDEN, NJ 08103 A CORP. OF NJ
Reel/Frame 003909/0160 →
Assignment of Assignors Interest. Sep 11, 1981
From: CARSON, DENNIS A.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION, 10666 NORTH TORREY PINES ROAD, LA JOLLA, CA 92037 A CORP. OF CA
Reel/Frame 003909/0158 →
Assignment of Assignors Interest. Dec 14, 1981
From: ZIMMERMAN, THEODORE S.; FULCHER, CAROL A.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION A CORP OF CA
Reel/Frame 003956/0820 →
Assignment of Assignors Interest. Apr 14, 1982
From: BITTLE, JAMES L.; LERNER, RICHARD A.
To: SCRIPPS CLINIC & RESEARCH FOUNDATION
Reel/Frame 004001/0072 →
Assignment of Assignors Interest. May 11, 1982
From: WEIGLE, WILLIAM O.; MORGAN, EDWARD L.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION, A CORP. OF CALIF.
Reel/Frame 003996/0267 →
Assignment of Assignors Interest. Aug 23, 1982
From: GREEN, NICOLA; ALEXANDER, STEPHEN
To: SCRIPPS CLINIC & RESEARCH FOUNDATION
Reel/Frame 004042/0051 →
Assignment of Assignors Interest. Dec 6, 1982
From: GOODMAN, MICHAEL G.; WEIGLE, WILLIAM O.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION
Reel/Frame 004066/0919 →
Assignment of Assignors Interest. May 23, 1983
From: ZIMMERMAN, THEODORE S.; FULCHER, CAROL A.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION
Reel/Frame 004144/0093 →
Assignment of Assignors Interest. Jun 28, 1983
From: HOUGHTEN, RICHARD A.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION
Reel/Frame 004147/0888 →
Assignment of Assignors Interest. Aug 3, 1983
From: COOPER, NIEL; MAYES, JAMES T.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION A CORP. OF CA
Reel/Frame 004152/0536 →
Assignment of Assignors Interest. Apr 13, 1984
From: SUTCLIFFE, J. GREGOR
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION, A CA CORP.
Reel/Frame 004244/0252 →
Assignment of Assignors Interest. May 24, 1984
From: THEOFILOPOULOS, ARGYRIOS N.; DIXON, FRANK J.; AGUADO-CELADA, MARIA-TERESA
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION, A CORP OF
Reel/Frame 004268/0815 →
Assignment of Assignors Interest. Jul 6, 1984
From: GOODMAN, MICHAEL G.; WEIGLE, WILLIAM O.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION A CORP OF CA
Reel/Frame 004277/0675 →
Assignment of Assignors Interest. Jul 9, 1984
From: COPPERSMITH, WARD J.; LA MOTTE, GEORGE B. III
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION
Reel/Frame 004277/0747 →
Assignment of Assignors Interest. Aug 16, 1984
From: NIMAN, HENRY L.; LERNER, RICHARD A.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION
Reel/Frame 004290/0057 →
Assignment of Assignors Interest. Sep 13, 1984
From: MORIARTY, ANN M.; ALEXANDER, HANNAH; LERNER, RICHARD A.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION A CA CORP
Reel/Frame 004300/0239 →
Assignment of Assignors Interest. Oct 15, 1984
From: MILICH, DAVID R.; CHISARI, FRANK V.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION A CA CORP.
Reel/Frame 004317/0957 →
Assignment of Assignors Interest. Oct 18, 1984
From: HOUGHTEN, RICHARD A.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION, A CA CORP.
Reel/Frame 004317/0574 →
Assignment of Assignors Interest. Jan 7, 1985
From: VAUGHAN, JOHN H.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION A CORP OF CA
Reel/Frame 004348/0912 →
Assignment of Assignors Interest. Jan 7, 1985
From: CARSON, DENNIS A.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION A CA CORP.
Reel/Frame 004348/0946 →
Assignment of Assignors Interest. Jan 7, 1985
From: MC MILLAN, SEAMUS L. H.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION A CA CORP.
Reel/Frame 004348/0945 →
Assignment of Assignors Interest. Jan 7, 1985
From: LERNER, RICHARD A.
To: SCRIPPS CLINIC AND RESEARCH FOUNDATION A CA CORP
Reel/Frame 004348/0944 →